Old UI: Optimizing Campaigns with A/B Testing
Why do A/B testing?
A/B testing is done to test multiple email copies and see which of the copies is working best. An email copy's performance is measured by its opens, (clicks) unsubscribe, and most importantly --replies.
Pro tip: Using email variations also improves your email deliverability. This is because sending emails with different variations will make it more difficult for spam filters to block you.
How to do A/B testing?
A/B testing can be easily done by creating multiple variations to an email step.
For a more detailed guide on email variations, you can check out this article -- Variations.
Which email variation is working best?
Each email variation has its own stats. Clicking each email variation, you can see the open, click, reply, and unsubscribe rates of the variation. The stats also show the number of prospects the variation has been sent to.
These stats will help you determine which email copy is the most effective.
How to export stats per email variation?
To export the statistics of each email step variation and see how well the variations do, go to the Organization's Dashboard and under 'Reports', click 'Download campaign detailed stats'.
The exported CSV provides detailed statistics of the step variations of each campaign within the Agency account.
However, note that it only stores variations data from the past 14 days.
This will provide you with a detailed CSV file that contains all step variations data from all campaigns the past 14-days.
How to stop sending an email variation that is not performing well?
The goal of A/B testing is to rule out the best email copy. If an email copy is not helping you receive replies, then you can stop sending it by pausing the email variation.
To pause an email variation, just click the triple-dot icon of the variation and then click Pause variation.
Warning: Avoid deleting email variations as doing so might cause journeys to run into an error. When a journey runs into an error, the prospect won't be able to receive further follow-ups.